IntraMedical Imaging
- Company typePrivate
- Founded1998
- HeadquartersHawthorne, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What IntraMedical Imaging does
IntraMedical Imaging, LLC is a privately held California medical device company founded in 1998 that develops, manufactures, and markets molecular imaging instruments used by surgical teams to detect cancer and abnormal tissue intraoperatively. The company's core product line is the Node Seeker family of gamma detection probes, anchored by the Node Seeker 2000 universal control unit — a touch-screen tablet with a 9-hour battery that interoperates with a catalog of interchangeable probes: standard and bent-tip probes (WG-140A/B) for sentinel lymph node biopsy, a laparoscopic probe (WG-140L) for minimally invasive oncology procedures, a narrow-tip probe (WG-140N) for radioguided parathyroidectomy, and a high-energy PET probe (WG-511) for FDG-based tumor localization. The probes use solid-state photomultipliers paired with LYSO crystals — detection technology drawn from PET scanner design — which the company claims produces approximately 2x the sensitivity of competing products such as the Neoprobe, based on head-to-head comparisons cited by named surgeons at Hoag Hospital Newport Beach and Providence Santa Monica. All probes are certified H2O2 sterilizable via Sterrad and Steris systems.
The company serves oncology surgeons, surgical oncologists, and the hospitals and ambulatory surgical centers where they operate, addressing procedures including sentinel lymph node biopsy for breast cancer and melanoma staging, radioguided parathyroidectomy, radioactive seed localization, and FDG-PET-guided tumor excision. IntraMedical sells through a hybrid model: direct quote-based enterprise sales with free product trials handled via [email protected] and a website contact form, complemented by a multi-region distributor network spanning North America, Europe, Asia, and the Middle East, with the company actively recruiting additional qualified regional partners. The firm is bootstrapped — no funding rounds, parent company, or subsidiaries are disclosed — and operates from a single headquarters at 12340 Santa Monica Blvd in Los Angeles.
IntraMedical Imaging firmographics
Firmographics- Name
- IntraMedical Imaging
- Legal name
- Intramedical Imaging, LLC
- Website
- https://intramedicalimaging.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
IntraMedical Imaging industry classification
Industry- Product category
- Surgical Molecular Imaging Devices
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG)
- akta.pro secondary industry
- Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)
Keywords
Where IntraMedical Imaging is headquartered
LocationHeadquarters
- HQ city
- Hawthorne
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
IntraMedical Imaging business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Medical Device Hardware Sales: Intramedical Imaging generates revenue through the sale of medical devices including the Node Seeker 2000 control unit and various gamma probe models (WG-140A/B Standard/Bent Tip, WG-140L Laparoscopic, WG-140N Narrow Tip, WG-511 PET Probe). The company sells directly to hospitals and through distribution partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free trial available for the Node Seeker system |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
IntraMedical Imaging product offering
Product offeringCore offering
IntraMedical Imaging develops, manufactures, and markets molecular imaging instruments — specifically the Node Seeker line of gamma detection probes and the Node Seeker 2000 universal control unit — used by surgeons during cancer operations to detect sentinel lymph nodes, parathyroid adenomas, radioactive seeds, and FDG-positive tumors. The system uses solid-state photomultipliers with LYSO crystals (technology similar to PET scanners) to deliver the highest published sensitivity in the market, approximately 2x that of the Neoprobe competitor.
Product overview
IntraMedical Imaging offers the Node Seeker line of gamma detection probes for intraoperative molecular imaging during cancer surgery. The product portfolio centers on the Node Seeker 2000 universal control unit (a touch-screen tablet) that connects to interchangeable gamma probes. The probe lineup includes: Standard/Bent Tip probes (WG-140A/B) for sentinel lymph node biopsy, Laparoscopic probes (WG-140L) for minimally invasive procedures, Narrow Tip probes (WG-140N) for parathyroidectomy, and High Energy PET probes (WG-511) for tumor localization. The system is designed for sentinel node mapping in breast cancer and melanoma, radioguided parathyroidectomy, radioactive seed localization, and FDG-based tumor detection. Probes use solid-state photomultipliers and LYSO crystals (similar to PET scanner technology) for enhanced sensitivity.
Differentiator
Problem solved
Functional benefit
Products and services
- Node Seeker 2000 Control Unit Universal touch-screen tablet control unit with 9-hour battery life that connects to any IMI gamma probe. Allows surgeons to switch between probe types during procedures using a 'change probe' button, and supports real-time count saving and battery monitoring. Sold to hospitals and surgical centers performing radioguided cancer surgery.
- Standard & Bent Tip Gamma Probe (WG-140A/B) Gamma detection probes for sentinel lymph node biopsy, available in 12.5mm and 14mm tip sizes in straight and bent tip configurations. Designed for surgeons performing sentinel lymph node mapping in breast cancer and melanoma.
- Laparoscopic Gamma Probe (WG-140L) Laparoscopic gamma probe for node biopsy and mapping in cervical, prostate, and gastric cancer procedures, available in 5mm and 10mm tip sizes. Used by surgical oncologists performing minimally invasive radioguided procedures.
- Narrow Tip Gamma Probe (WG-140N) Narrow-tip gamma probe for radioguided parathyroidectomy procedures, available in 6.25mm and 9mm tip sizes. Used by endocrine and head-and-neck surgeons for parathyroid adenoma localization.
- High Energy PET Probe (WG-511) High-energy PET probe based on positron emission tomography technology for tumor localization. Uses FDG radiopharmaceutical to detect 'hot spot' tumors during surgery and evaluate surgical margins for residual disease.
Quantifiable outcome
- 2x higher sensitivity compared to Neoprobe in head-to-head trials
- +1 more outcomes
Companies that use IntraMedical Imaging
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles1 record
IntraMedical Imaging technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
IntraMedical Imaging partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Distribution Partners (North America, Europe, Asia, Middle East)coreIntramedical Imaging works with a network of trusted distributors across North America, Europe, Asia, and the Middle East. These partners are key in bringing their surgical navigation tools (Node Seeker gamma probes) to hospitals and clinics worldwide. The company is actively seeking to expand into new regions with qualified distributors.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
IntraMedical Imaging competitors and assessment
Company assessmentBroad incumbents
- Stryker: Diversified surgical and medical device major with capital equipment and instruments sold to the same hospital OR customers IMI targets. Not a gamma-probe competitor, but competes for OR budgets and surgical navigation contracts.
- BD (Becton Dickinson): Global medical technology company with surgical instruments, biosciences, and interventional franchises. Competes in the OR for instruments, supplies, and oncology-surgery budgets serving IMI's same hospital accounts.
- Karl Storz: German-based leader in endoscopic and laparoscopic surgical visualization systems. Sells into the same OR channel and minimally invasive surgery use cases (e.g., laparoscopic node dissection) that IMI's WG-140L laparoscopic probe addresses.
- Hologic: Large women's health and surgical imaging company with breast surgery and lesion localization franchises (e.g., LOCalizer wire-free guidance). Overlaps with IMI in breast-cancer surgical workflows but as part of a much broader diagnostics and surgical portfolio.
- Medtronic: Global medtech incumbent with surgical and oncology franchises that overlap with IMI's hospital customer base. Competes broadly for surgical imaging, energy, and instrument budgets across large hospital systems.
Emerging players
- ViewRay: Developer of MR-guided radiation therapy systems used in oncology treatment. Thematically adjacent — radioguided, oncology-focused hardware — but addresses the treatment rather than intraoperative detection setting.
- Sirtex Medical: Radiation oncology / radiopharmaceutical company focused on liver-directed and other targeted therapies. Adjacent to IMI in radioguided oncology workflows but emphasizes therapy rather than intraoperative detection.
- Penumbra: Interventional medical device company with expanding surgical and oncology adjacencies. Competes for hospital capital equipment spend in overlapping surgical specialties.
Others
- AngioDynamics: Interventional medical device manufacturer serving vascular access, oncology, and surgical customers. Operates in similar hospital procurement channels but with a different clinical focus.
Direct peers
- Devicor Medical Products (Neoprobe / Mammotome): Mammotome, a Danaher-owned business, sells the Neoprobe gamma detection system — the named head-to-head competitor to IMI's Node Seeker. Directly competes in intraoperative sentinel lymph node biopsy with overlapping clinical use cases.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
IntraMedical Imaging social profiles
Digital presenceIntraMedical Imaging financial estimates
Financial estimateRevenue estimate
Valuation estimate
IntraMedical Imaging leadership team
Management profileNumber of profiles
IntraMedical Imaging funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IntraMedical Imaging M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IntraMedical Imaging
What does IntraMedical Imaging do?
IntraMedical Imaging develops, manufactures, and markets molecular imaging instruments — specifically the Node Seeker line of gamma detection probes and the Node Seeker 2000 universal control unit — used by surgeons during cancer operations to detect sentinel lymph nodes, parathyroid adenomas, radioactive seeds, and FDG-positive tumors. The system uses solid-state photomultipliers with LYSO crystals (technology similar to PET scanners) to deliver the highest published sensitivity in the market, approximately 2x that of the Neoprobe competitor.
Is IntraMedical Imaging a public or private company?
IntraMedical Imaging is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IntraMedical Imaging founded?
IntraMedical Imaging was founded in 1998. It employs 1 to 10 people.
Where is IntraMedical Imaging based?
IntraMedical Imaging is headquartered in Hawthorne, United States, in the North America region.
How does IntraMedical Imaging make money?
One revenue line is on record: medical Device Hardware Sales.
Who are IntraMedical Imaging's main competitors?
Broad incumbents on record are Stryker, BD (Becton Dickinson), Karl Storz, Hologic and Medtronic. Emerging players are ViewRay, Sirtex Medical and Penumbra. AngioDynamics is listed as an others. Devicor Medical Products (Neoprobe / Mammotome) is listed as a direct peer.
Does IntraMedical Imaging have an API?
No public API is recorded for IntraMedical Imaging.
What industry is IntraMedical Imaging in?
IntraMedical Imaging's product category is Surgical Molecular Imaging Devices. Its primary akta.pro industry code is HLAHABAG, Interventional Radiology & Image-Guided Therapy Systems, with a secondary code of HLAHABAE, Nuclear Medicine & Molecular Imaging (SPECT/PET). Its NAICS code is 3345 and its SIC code is 3841.